Search research articles
Contact Us
Filters
Showing results (181-190 of 305) with videos related to
Page
of 31
Sort By:
Cancer
|
March 15, 1980
Radiation therapy in stage II ovarian carcinoma: the influence of histologic grade
P M Mauch, R L Ehrmann, C T Griffiths, et al.
Journal of Clinical Microbiology
|
March 1, 1996
Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria
S K Schmitt, C Knapp, G S Hall, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1993
Comparison of vidas Clostridium difficile toxin-A assay and premier C. difficile toxin-A assay to cytotoxin-B tissue culture assay for the detection of toxins of C. difficile
C C Knapp, R L Sandin, G S Hall, et al.
Gynecologic Oncology
|
September 1, 1991
Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433)
S E Brooks, J Timmerman, C C Lau, et al.
Radiology
|
March 1, 1982
The role of postoperative local or regional irradiation in the treatment of stage I ovarian cancer
W D Powlis, P Mauch, R L Ehrmann, et al.
Transplantation Proceedings
|
June 1, 1997
Characterization of baboon vertebral body marrow
N S Kenyon, J C Knapp, X M Xu, et al.
American Journal of Obstetrics and Gynecology
|
April 15, 1984
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix
J M Niloff, T L Klug, E Schaetzl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 1, 1992
Analysis of cytotoxicity of 131I-labelled OC125 F(ab')2 on human epithelial ovarian cancer cell lines
E Schneider-Gädicke, J L Humm, C C Lau, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 12, 2007
Hepatic effects of Cimicifuga racemosa extract in vivo and in vitro
S Lüde, M Török, S Dieterle, et al.
Obstetrics and Gynecology
|
February 1, 1987
CA 125 for the monitoring of ovarian carcinoma during primary therapy
P T Lavin, R C Knapp, G Malkasian, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 305) with videos related to
Sort By:
Page
of 31
Cancer
|
March 15, 1980
Radiation therapy in stage II ovarian carcinoma: the influence of histologic grade
P M Mauch, R L Ehrmann, C T Griffiths, et al.
Journal of Clinical Microbiology
|
March 1, 1996
Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria
S K Schmitt, C Knapp, G S Hall, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1993
Comparison of vidas Clostridium difficile toxin-A assay and premier C. difficile toxin-A assay to cytotoxin-B tissue culture assay for the detection of toxins of C. difficile
C C Knapp, R L Sandin, G S Hall, et al.
Gynecologic Oncology
|
September 1, 1991
Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433)
S E Brooks, J Timmerman, C C Lau, et al.
Radiology
|
March 1, 1982
The role of postoperative local or regional irradiation in the treatment of stage I ovarian cancer
W D Powlis, P Mauch, R L Ehrmann, et al.
Transplantation Proceedings
|
June 1, 1997
Characterization of baboon vertebral body marrow
N S Kenyon, J C Knapp, X M Xu, et al.
American Journal of Obstetrics and Gynecology
|
April 15, 1984
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix
J M Niloff, T L Klug, E Schaetzl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 1, 1992
Analysis of cytotoxicity of 131I-labelled OC125 F(ab')2 on human epithelial ovarian cancer cell lines
E Schneider-Gädicke, J L Humm, C C Lau, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 12, 2007
Hepatic effects of Cimicifuga racemosa extract in vivo and in vitro
S Lüde, M Török, S Dieterle, et al.
Obstetrics and Gynecology
|
February 1, 1987
CA 125 for the monitoring of ovarian carcinoma during primary therapy
P T Lavin, R C Knapp, G Malkasian, et al.
Page
of 31